1 / 11

Angiogenesis in Viral Immunoinflammatory Lesions

Angiogenesis in Viral Immunoinflammatory Lesions. Barry T. Rouse University of Tennessee Part 4. Does control of angiogenesis represent a smart approach to control stromal keratitis?. Problem: many factors to deal with. EMAP II Endothelial Monocyte Activating Polypeptide.

asha
Download Presentation

Angiogenesis in Viral Immunoinflammatory Lesions

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Angiogenesis in Viral Immunoinflammatory Lesions Barry T. Rouse University of Tennessee Part 4

  2. Does control of angiogenesis represent a smart approach to control stromal keratitis? • Problem: many factors to deal with

  3. EMAP IIEndothelial Monocyte Activating Polypeptide • Cytokine with several effects on neovascularization • Apoptosis of vascular endothelial cells • Upregulates TNF receptors – so TNFa induces apoptosis • Activates tissue factors and blood clots • Proinflammatory effects • Rationale - targets growing blood vessels so should inhibit effects of several angiogenic factors

  4. EMAP II induces apoptosis in vascular endothelial cells in vitro and in vivo 40 * b a Epi * 30 Lim # of Apoptotic Cells/HPF 20 Endo 10 0 0 10 100 1000 EMAP II (ng/ml)

  5. EMAP II suppresses neovascularization in murine HSK Control EMAP II 20 c EMAP II i * * c D2 p.I. D8 p.I. D15 p.I. Control * 15 i * c Angiogenesis Score 10 c i * 5 c c 0 0 5 10 15 20 25 Days p.i.

  6. Control EMAP II D8 D8 D15 D15 D15 D15 F F E E EMAP II Suppresses HSK lesion score 5 * EMAP II * Control 4 * 3 HSK Lesion Score 2 * 1 0 0 5 10 15 20 25 Days p.i.

  7. Future approaches – possible siRNA targeting multiple angiogenesis factors

  8. Preliminary study • Plasmid encoding siRNA expressed following intra-stromal or sub-conjunctival injection • Mixture of siRNA inhibiting VEGF and VEGF receptors gave significant inhibition of angiogenesis induced by CpG

  9. Inhibition of CpG induced angiogenesis by siRNA delivery CpG + siLacZ Day 4 CpG + siVEGF, R1, R2 Day 4

  10. General Conclusions • Herpes induced stromal keratitis an immunoinflammatory lesion • Neovascularization a major step in pathogenesis • HSV induces angiogenesis indirectly • Control of angiogenesis inhibits SK • Need multiple approaches for satisfactory therapy

  11. Dennis Klinman Margaret Schwartz Napoleone Ferrara Mei Zheng Bum-Seok Kim Kaustuv Banerjee Partha Biswas Sujin Lee Colleagues Involved

More Related